Inhibition of complete development of Cryptosporidium parvum in Caco-2 cells [5]

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 11, 1996, Pages 897-900

  Egraz Bernard, M ^a   Favennec, L ^a,b   Agnamey, P ^a   Ballet, J J ^b   Brasseur, P ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b CHU Clemenceau   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; PAROMOMYCIN; SINEFUNGIN;

CRYPTOSPORIDIUM PARVUM; HUMAN; HUMAN CELL; LETTER; NONHUMAN; PARASITE DEVELOPMENT; PRIORITY JOURNAL;

EID: 0029730927     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01691230     Document Type: Letter

References (12)

1. Current WL, Garcia L: Cryptosporidiosis. Clinical Microbiology Reviews 1990, 4: 325-358.
2. Lemeteil D, Roussel F, Favennec L, Ballet JJ, Brasseur P: Assessment of candidate anticryptosporidial agents in an immunosuppressed rat model. Journal of Infectious Diseases 1993, 167: 766-769.
3. Webster LT Jr: Paromomycin. In: Gilman AG, Rall TW, Nies AS, Taylor P (ed): The pharmacologic basis of therapeutics. Pergamon Press, New York, 1990 p. 1005-1006.
4. Marshall RJ, Flanigan TP: Paromomycin inhibits Cryptosporidium infection of a human enterocyte cell line. Journal of Infectious Diseases 1992, 165: 772-774.
5. Geze MP, Blanchard P, Fourrey JL, Robert-Gero M: Synthesis of sinefungin and its C-6′ epimer. Journal of the American Chemical Society 1983, 105: 7638-7640.
6. Bachrach U, Schnur LF, El-On J, Greenblatt C, Perlman E, Robert-Gero M, Lederer E: Inhibitory activity of sinefungin and SIBA on the growth of promastigotes and amastigotes from different species of Leishmania. FEBS Letters 1980, 121: 287-291.
7. Ferrante A, Ljungström I, Lederer E: Antitoxoplasmosis properties of sinefungin in mice. Comptes Rendus de l'Académie des Sciences 1988, 306: 109-113.
8. Tharasse-Bloch C, Brasseur P, Favennec L, Marchand J: Determination of sinefungin in rat plasma by high-performance liquid chromatography. Journal of Chromatography B 1995, 674: 247-252.
9. Favennec L, Egraz-Bernard M, Comby E, Lemeteil D, Ballet JJ, Brasseur P: Immunofluorescence detection of Cryptosporidium parvum in Caco-2 cells: a new screening method for anticryptosporidial agents. Journal of Eukaryotic Microbiology 1994, 41, Supplement: 39.
10. Upton SJ, Tilley M, Mitschler RR, Oppert BS: Incorporation of exogenous uracil by Cryptosporidium parvum in vitro. Journal of Clinical Microbiology 1991, 29: 1062-1065.
11. Edlind TD: Susceptibility of Giardia lamblia to aminoglucoside protein synthesis inhibitor: correlation with rRNA structure. Antimicrobial Agents and Chemotherapy 1989, 33: 484-488.
12. Bacchi CJ: Resistance to clinical drugs in African trypanosomes. Parasitology Today 1993, 9: 190-193.